{"id":4847,"date":"2025-03-07T01:55:54","date_gmt":"2025-03-07T00:55:54","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/"},"modified":"2025-03-07T01:55:55","modified_gmt":"2025-03-07T00:55:55","slug":"la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/","title":{"rendered":"La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2025\/fda-approves-tnkase-fo.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/hires\/2025\/fda-approves-tnkase-fo.jpg\" data-sub-html=\"\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>La Food and Drug Administration des \u00c9tats-Unis a approuv\u00e9 la TNKase (t\u00e9nectplase), un agent thrombolytique ou dissolvant des caillots, pour le traitement de l&rsquo;AVC isch\u00e9mique aigu chez les adultes.<\/p>\n<p>La TNKase est livr\u00e9e comme un seul bolus intraveineux de cinq secondes. Ceci est consid\u00e9rablement plus rapide que la norme de soins, l&rsquo;activation (AltePlase), qui est administr\u00e9e comme un bolus intraveineux suivi d&rsquo;une perfusion de 60 minutes. Genentech, le fabricant de TNKase, affirme qu&rsquo;une nouvelle configuration de flacon de 25 mg sera disponible dans les prochains mois.<\/p>\n<p>L&rsquo;approbation est bas\u00e9e sur une \u00e9tude comparant \u00e0 la TNKase \u00e0 l&rsquo;activation chez les patients atteints d&rsquo;un AVC isch\u00e9mique aigu qui a pr\u00e9sent\u00e9 un d\u00e9ficit neurologique invalidante. Les r\u00e9sultats montrent que la TNKase \u00e9tait comparable \u00e0 l&rsquo;activation en termes d&rsquo;efficacit\u00e9 et de s\u00e9curit\u00e9.<\/p>\n<p>L&rsquo;AVC affecte plus de 795 000 personnes chaque ann\u00e9e aux \u00c9tats-Unis. C&rsquo;est la principale cause d&rsquo;invalidit\u00e9 \u00e0 long terme et la cinqui\u00e8me cause de d\u00e9c\u00e8s. \u00c9tant donn\u00e9 que les l\u00e9sions c\u00e9r\u00e9brales se produisent et progressent rapidement lors d&rsquo;un AVC isch\u00e9mique aigu, des soins m\u00e9dicaux imm\u00e9diats et \u00e0 action rapide sont vitaux.<\/p>\n<p>\u00ab\u00a0L&rsquo;approbation d&rsquo;aujourd&rsquo;hui est un pas en avant significatif et souligne notre engagement \u00e0 faire avancer les options de traitement des AVC pour les patients\u00a0\u00bb, a d\u00e9clar\u00e9 Levit Garraway, MD, Ph.D., m\u00e9decin en chef et chef du d\u00e9veloppement mondial de produits chez Genentech, dans un communiqu\u00e9. \u00ab\u00a0TNKase fournit une administration plus rapide et plus simple, qui peut \u00eatre essentielle pour quiconque a affaire \u00e0 un accident vasculaire c\u00e9r\u00e9bral.\u00a0\u00bb<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>La Food and Drug Administration des \u00c9tats-Unis a approuv\u00e9 la TNKase (t\u00e9nectplase), un agent thrombolytique<\/p>\n","protected":false},"author":1,"featured_media":4848,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[3273,321,1979,447,4205,8,4364],"class_list":["post-4847","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-aigu","tag-approuve","tag-avc","tag-fda","tag-ischemique","tag-pour","tag-tnkase","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"La Food and Drug Administration des \u00c9tats-Unis a approuv\u00e9 la TNKase (t\u00e9nectplase), un agent thrombolytique\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-07T00:55:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-07T00:55:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1741308954_La-FDA-approuve-la-tnkase-pour-un-AVC-ischemique-aigu.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1391\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu\",\"datePublished\":\"2025-03-07T00:55:54+00:00\",\"dateModified\":\"2025-03-07T00:55:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/\"},\"wordCount\":290,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1741308954_La-FDA-approuve-la-tnkase-pour-un-AVC-ischemique-aigu.jpg\",\"keywords\":[\"aigu\",\"approuve\",\"AVC\",\"FDA\",\"isch\u00e9mique\",\"pour\",\"tnkase\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/\",\"name\":\"La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1741308954_La-FDA-approuve-la-tnkase-pour-un-AVC-ischemique-aigu.jpg\",\"datePublished\":\"2025-03-07T00:55:54+00:00\",\"dateModified\":\"2025-03-07T00:55:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1741308954_La-FDA-approuve-la-tnkase-pour-un-AVC-ischemique-aigu.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1741308954_La-FDA-approuve-la-tnkase-pour-un-AVC-ischemique-aigu.jpg\",\"width\":1391,\"height\":800,\"caption\":\"La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/","og_locale":"fr_FR","og_type":"article","og_title":"La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu - RVH-Synergie.org","og_description":"La Food and Drug Administration des \u00c9tats-Unis a approuv\u00e9 la TNKase (t\u00e9nectplase), un agent thrombolytique","og_url":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/","og_site_name":"RVH-Synergie","article_published_time":"2025-03-07T00:55:54+00:00","article_modified_time":"2025-03-07T00:55:55+00:00","og_image":[{"width":1391,"height":800,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1741308954_La-FDA-approuve-la-tnkase-pour-un-AVC-ischemique-aigu.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu","datePublished":"2025-03-07T00:55:54+00:00","dateModified":"2025-03-07T00:55:55+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/"},"wordCount":290,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1741308954_La-FDA-approuve-la-tnkase-pour-un-AVC-ischemique-aigu.jpg","keywords":["aigu","approuve","AVC","FDA","isch\u00e9mique","pour","tnkase"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/","url":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/","name":"La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1741308954_La-FDA-approuve-la-tnkase-pour-un-AVC-ischemique-aigu.jpg","datePublished":"2025-03-07T00:55:54+00:00","dateModified":"2025-03-07T00:55:55+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1741308954_La-FDA-approuve-la-tnkase-pour-un-AVC-ischemique-aigu.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/03\/1741308954_La-FDA-approuve-la-tnkase-pour-un-AVC-ischemique-aigu.jpg","width":1391,"height":800,"caption":"La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-la-tnkase-pour-un-avc-ischemique-aigu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"La FDA approuve la tnkase pour un AVC isch\u00e9mique aigu"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/4847","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=4847"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/4847\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/4848"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=4847"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=4847"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=4847"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}